封面
市场调查报告书
商品编码
1575809

全球溶血卵磷脂市场 - 2024-2031

Global Lysolecithin Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 215 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球溶血卵磷脂市场在2023年达到1.575亿美元,预计2031年将达到2.843亿美元,2024-2031年预测期间复合年增长率为7.7%。

溶血卵磷脂具有独特的特性,包括其形成胶束和脂质体的能力,使其成为药物传输系统的有前途的选择。研究人员正在研究溶血卵磷脂封装和运输各种活性药物成分的潜力,旨在提高其生物利用度和治疗效果。

此外,该行业的主要参与者推出的创新产品将推动该市场的成长。例如,建明工业公司推出了LYSOFORTE,这是一种源自溶血磷脂的营养乳化剂,专门用于增强畜禽饲料中脂肪、油和脂溶性营养素等高能量饲料成分的消化和吸收。其创新配方优化了脂肪消化的三个重要阶段:乳化、水解和吸收。

动力学

消费者对健康益处的认知不断提高

全球溶血卵磷脂市场的需求由多种因素驱动。关键因素之一是消费者对健康益处的认识不断提高。消费者对溶血卵磷脂健康益处的认识正在显着影响其融入多个行业的各种产品,特别是在全球市场。研究表明,溶血卵磷脂可以改善大脑健康和认知功能,从而吸引那些想要提高思维清晰度和记忆力的消费者,尤其是老年人群。

人们对天然和非基因改造成分的日益青睐使得溶血卵磷脂成为清洁标籤产品的首选。注重健康的消费者越来越多地寻找含有熟悉成分且符合其饮食选择的产品。溶血卵磷脂的适应性使其能够融入多个领域的各种产品中,包括食品和饮料、营养保健品和个人护理品。

生物技术和生命科学领域的不断进步和创新为溶血卵磷脂的使用创造了新的机会,特别是在医药和健康相关产品领域。随着消费者健康意识的增强,对具有针对性健康益处的功能性食品和膳食补充剂的需求显着增加。

此外,该行业的主要参与者产品发布和关键开发将推动该市场的成长。例如,2023年8月,日兴化学推出了Nikkol Lecinol MFL,该产品旨在透过刺激神经酰胺和聚丝蛋白的产生来增强皮肤的屏障功能。这种成分富含溶血磷脂酸,这是一种溶血卵磷脂,以其对錶皮细胞的广泛功效而闻名。

药物配方数量不断增加

随着药物开发的不断进步,溶血卵磷脂因其作为乳化剂、增溶剂和稳定剂的特性而越来越受欢迎,这对于提高药物输送系统的有效性至关重要。製药业不断开发新的配方,需要提高活性成分的生物利用度、控制释放和增强吸收。

溶血卵磷脂是一种天然磷脂,用于提高疏水性药物的溶解度,使其成为各种药物製剂的首选。它形成脂质体和稳定乳液的能力增强了药物的传递和吸收,这在口服、局部和注射药物应用中尤其重要。

随着製药市场对更复杂药物配方的需求增加,对溶血卵磷脂等功能性成分的需求也增加。此外,个人化医疗的趋势(通常涉及专门的药物输送系统)预计将促进溶血卵磷脂在市场上的使用。製药公司正在利用溶血卵磷脂来创造更有效、对患者友善的药物产品,从而推动全球溶血卵磷脂市场的成长。

更便宜的合成乳化剂的可用性

与溶血卵磷脂等天然替代品相比,聚山梨醇酯、甘油单酯和甘油二酯等合成乳化剂以较低的成本广泛使用。这些合成乳化剂通常具有类似的功能优势,例如改善食品、化妆品和药品的质地、稳定性和保质期。因此,寻求降低成本的製造商倾向于选择这些价格较低的产品,而不是溶血卵磷脂,特别是在加工食品和大众市场个人护理产品等价格敏感的市场。

此外,合成乳化剂的生产往往更具可扩展性,并且受农业供应链的影响较小,而农业供应链通常会影响天然溶血卵磷脂的可用性和定价。这进一步巩固了合成乳化剂在市场上的地位,因为它们可以以一致的品质和数量生产,使它们比天然乳化剂更具优势。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 消费者对健康益处的认知不断提高
      • 药物配方数量不断增加
    • 限制
      • 更便宜的合成乳化剂的可用性
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 监管分析
  • 定价分析
  • 专利分析
  • SWOT分析
  • 供应链分析
  • 价值链分析
  • 进出口分析
  • 临床试验分析
  • 消费者分析
  • 可持续性分析
  • 热图
  • B2B分析

第 6 章:按来源

  • 植物性
    • 大豆
    • 向日葵
    • 油菜籽(油菜籽)
  • 以动物为基础
    • 天竺鼠
    • 牛科

第 7 章:按类型

  • 水解溶血卵磷脂
    • 水解液
    • 脱油解
  • 化学改质溶血卵磷脂
  • 其他的

第 8 章:按形式

  • 粉末
  • 液体
  • 颗粒剂

第 9 章:按申请

  • 糖果点心
  • 麵包店
  • 食品补充剂
  • 动物饲料
  • 乳製品
  • 个人护理和化妆品
  • 植物性替代品
  • 其他的

第 10 章:最终用户

  • 食品和饮料
  • 药品
  • 化妆品
  • 营养保健品

第 11 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 12 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章:公司简介

  • Kemin Industries, Inc.
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Cargill, Inc.
  • Lipoid GmbH
  • Sternchemie GmbH & Co. KG
  • Alexmo Cosmetics
  • Cayman Chemical
  • Creative Biolabs
  • GlpBio Technology
  • Larodan AB
  • Biosynth Ltd

第 14 章:附录

简介目录
Product Code: FB8686

Overview

The Global Lysolecithin Market reached US$ 157.5 million in 2023 and is expected to reach US$ 284.3 million by 2031, growing at a CAGR of 7.7% during the forecast period 2024-2031.

Lysolecithin possesses unique characteristics, including its capacity to form micelles and liposomes, which make it a promising option for drug delivery systems. Researchers are investigating the potential of lysolecithin to encapsulate and transport various active pharmaceutical ingredients, intending to enhance their bioavailability and therapeutic effectiveness.

Further, key players in the industry launching innovative products that would drive this market growth. For instance, Kemin Industries, Inc. introduced LYSOFORTE a nutritional emulsifier derived from lysophospholipids, specifically designed to enhance the digestion and absorption of energy-dense feed components such as fats, oils and fat-soluble nutrients in livestock and poultry diets. Its innovative formulation optimizes three essential stages of fat digestion: emulsification, hydrolysis and absorption.

Dynamics

Rising Consumer Awareness of Health Benefits

The demand for the global lysolecithin market is driven by multiple factors. One of the key factors is the rising consumer awareness of health benefits. Consumer awareness of lysolecithin's health benefits is significantly influencing its incorporation into various products across multiple sectors, particularly in the global market. Studies indicate that lysolecithin may improve brain health and cognitive function, making it appealing to consumers who want to boost mental clarity and memory, particularly within aging populations.

The growing preference for natural and non-GMO ingredients has made lysolecithin a favored option in clean-label products. Health-conscious consumers are increasingly looking for items with familiar ingredients that match their dietary choices. Lysolecithin's adaptability enables its incorporation into a wide variety of products across several sectors, including food and beverages, nutraceuticals and personal care.

Ongoing advancements and innovations in biotechnology and life sciences are creating new opportunities for the use of lysolecithin, especially in the areas of medicine and health-related products. As consumers grow more health-conscious, there is a significant rise in the demand for functional foods and dietary supplements that offer targeted health benefits.

Moreover, key players in the industry product launches and key developments that would drive this market growth. For instance, in August 2023, Nikko Chemicals launched Nikkol Lecinol MFL, a product aimed at enhancing the skin's barrier function by stimulating the production of ceramides and filaggrin. This ingredient is rich in lysophosphatidic acid, a type of lysolecithin known for its extensive efficacy on epidermal cells.

Increasing Number of Drug Formulations

As drug development continues to advance, lysolecithin is gaining popularity for its properties as an emulsifier, solubilizer and stabilizer, which are crucial in enhancing the effectiveness of drug delivery systems. The pharmaceutical industry is constantly developing new formulations that require improved bioavailability, controlled release and enhanced absorption of active ingredients.

Lysolecithin, being a natural phospholipid, is used to improve the solubility of hydrophobic drugs, making it a preferred choice in various drug formulations. Its ability to form liposomes and stabilize emulsions enhances the delivery and absorption of medications, which is particularly important in oral, topical and injectable drug applications.

As the demand for more complex drug formulations rises in the pharmaceutical market, the need for functional ingredients like lysolecithin increases. Furthermore, the trend toward personalized medicine, which often involves specialized drug delivery systems, is expected to boost the use of lysolecithin in the market. Pharmaceutical companies are leveraging lysolecithin to create more effective and patient-friendly drug products, thereby driving the global lysolecithin market's growth.

Availability of Cheaper Synthetic Emulsifiers

Synthetic emulsifiers such as polysorbates, mono- and diglycerides and others are widely available at lower costs compared to natural alternatives like lysolecithin. These synthetic emulsifiers often provide similar functional benefits, such as improving texture, stability and shelf life in food, cosmetic and pharmaceutical products. As a result, manufacturers seeking to reduce costs are inclined to choose these lower-priced options over lysolecithin, especially in price-sensitive markets like processed foods and mass-market personal care products.

Additionally, the production of synthetic emulsifiers tends to be more scalable and less affected by the agricultural supply chain, which often impacts the availability and pricing of natural lysolecithin. This further solidifies the position of synthetic emulsifiers in the market, as they can be produced at a consistent quality and quantity, giving them an edge over their natural counterparts.

Segment Analysis

The global lysolecithin market is segmented based on source, type, form, application, end-user and region.

Diverse Applications and Various Health Benefits of Soy

Soy lysolecithin has become a widely used emulsifier in various food products due to its ability to enhance texture, stability and shelf life. It plays a vital role across various sectors, including food, pharmaceuticals and cosmetics. With consumers increasingly favoring healthier and more natural products, the demand for soy lysolecithin is anticipated to keep rising, growing because of its diverse applications and various health benefits. This trend creates substantial opportunities for manufacturers and suppliers in the lysolecithin market.

Soy lysolecithin is being explored for its potential use in drug delivery systems. Its distinctive characteristics allow it to serve as an effective medium for encapsulating active pharmaceutical ingredients, thereby improving their bioavailability and therapeutic effectiveness. Moreover, key players in the industry introduce various products in multiple sectors and key developments that would propel this segment's growth in the market.

For instance, in January 2024, Cosphatec launched two new products, Cosphaderm E NGM Natural and Cosphaderm PA-12, that adhere to the COSMOS and NATRUE certification standards for natural and organic cosmetic ingredients. This launch underscores Cosphatec's dedication to providing sustainable and eco-friendly raw materials for the cosmetics industry. Cosphaderm E NGM Natural is a liquid lysolecithin derived from soybeans.

Lysolecithin is an enzymatically modified form of lecithin, where a fatty acid has been removed through enzymatic processing. This modification results in a product with enhanced properties compared to regular lecithin. Similarly, Amitex India introduced the AmiLife Enzymatically Hydrolyzed Soya Lecithin (E322). It is derived from non-GMO soy lecithin. Through enzymatic hydrolysis, this lecithin undergoes modification to optimize its functional properties, making it suitable for diverse applications in the food industry and animal nutrition sectors.

Geographical Penetration

Expansion of the Food Processing Industry in Asia-Pacific

The increasing consumer preference for natural and non-GMO ingredients in food products is a prominent trend, especially in countries like India and China. As consumers in these regions become more health-conscious, they actively seek products that align with their dietary choices. Lysolecithin, which is derived from soy lecithin, fulfills these demands as it is viewed as a healthier alternative to synthetic emulsifiers.

The rapid expansion of the food processing industry in the Asia-Pacific region is a major factor driving the demand for lysolecithin as an emulsifier. Lysolecithin is extensively utilized in various food products, including baked goods, dairy items and convenience foods. The increasing consumption of processed and ready-to-eat meals, fueled by changing lifestyles and urbanization, has further heightened the need for effective emulsifiers like lysolecithin.

As urbanization progresses and consumer habits shift towards more convenient food options, the role of lysolecithin in food formulations is expected to grow, catering to both manufacturers' requirements and consumers' desires for high-quality processed foods. There is a rising awareness of the health advantages associated with lysolecithin, such as its capacity to improve cognitive function, lower cholesterol levels and support liver health helps to propel this market growth in this region.

Key player strategies such as partnerships & collaborations and technological advancements would drive this market growth. For instance, Prathista Industries has introduced a non-hormonal and naturally occurring feed supplement known as Pro-Lyso (Lysolecithin), developed in collaboration with the Indian Institute of Chemical Technology (IICT) in Hyderabad. This innovative product utilizes established biotechnology processes to enhance animal nutrition, specifically targeting poultry and shrimp.

Competitive Landscape

Bifurcation of how emerging players and startups function in the market

Emerging players and startups play a crucial role in the evolving lysolecithin market. While established players dominate large portions of the market, newer entrants are bringing innovation, agility and unique business models that challenge traditional supply chains. Many startups work closely with academic or research institutions to leverage the latest technological advancements in enzymatic processing or sustainable production methods. By adopting cutting-edge processes, they can produce high-quality lysolecithin at lower costs or with enhanced functionality, giving them a competitive advantage.

Market Presence: While startups are only entering the market, emerging players have made a name for themselves with their current offerings.

Resources: While startups frequently work with a small amount of cash, emerging players usually have access to additional resources, such as supply chains and finance.

Innovation Focus: While emerging players expand on previously developed ideas, Startups are catering to the growing demand for plant-based foods, positioning their lysolecithin products as natural emulsifiers in plant-based meat, dairy alternatives and clean-label processed foods. These companies are branding themselves as enablers of sustainable, ethical food production.

Brand Recognition: While startups are still developing their reputation and recognition in the industry, emerging players already have a certain amount of brand awareness. Startups use digital platforms to build their brand identity, often focusing on ethical sourcing, sustainability and transparency.

The major global players in the market include Kemin Industries, Inc., Cargill, Inc., Lipoid GmbH, Sternchemie GmbH & Co. KG, Alexmo Cosmetics, Cayman Chemical, Creative Biolabs, GlpBio Technology, Larodan AB and Biosynth Ltd.

Aim of trial: The objectives of this study were to evaluate three different strategies of LYSO supplementation on feedlot performance, carcass characteristics, nutrient digestion and the longissimus fatty acid profile of Bos indicus and Bos indicus crosses and to validate an innovative environmental index named InComfort (InCl) as a tool to evaluate DMI during natural heat stress events in the course of conducting open dry-lot feedlot experiments.

Materials and methods: All procedures and protocols involving the use of animals were approved by the Ethics Committee on animal use of the Sao Paulo State University "Julio de Mesquita Filho" (UNESP; Protocol number: 016339/19).

Results: In experiment (1), no differences were detected for IBW (P = 0.791). The use of LYSO increased FBW (P = 0.022); however, no differences were detected among the LYSO phase-feeding treatments (P = 0.191). Conversely, a tendency was observed (P = 0.060) when NON was compared with the pairwise comparisons of the means (GRO). In experiment (2), a treatment X breed interaction was observed, in which CEA animals had a higher IBW (P < 0.001; 406.42 vs. 372.55 for CEA and NEL, respectively); however, no differences were detected for FBW (P = 0.223; data not shown). Moreover, NEL animals from FIN also had greater DMI (P < 0.05) than NON, GRO and ALL cohorts within the same genotype but did not differ from CEA in the ALL and GRO protocols.

Conclusion: Overall, feeding LYSO during growing period (GRO) and finishing period (FIN) enhanced feedlot performance and should lead to higher intakes during very hot days of the finishing feeding period.

Consumer Analysis

Consumer analysis in the lysolecithin market helps to understand the behavior, preferences and needs of the market's various consumer segments. This analysis focuses on identifying the main industries and end-users of lysolecithin, their purchasing drivers, key concerns and the factors influencing their decision-making processes.

Consumers, particularly in the food, cosmetics and nutraceutical industries, increasingly prefer products that are natural, minimally processed and free from artificial additives. Lysolecithin, derived from natural sources like soybeans and sunflower seeds, aligns well with this trend. Although lysolecithin is favored for its natural properties, price remains a critical factor, particularly for large-scale users in the food and feed industries. Fluctuations in the prices of raw materials can significantly impact consumer purchasing decisions.

Sustainability Analysis

Sustainability is becoming a central focus for companies operating in the lysolecithin market. As industries worldwide move toward environmentally responsible practices, the lysolecithin market is being shaped by efforts to address environmental, social and governance factors. Sustainability in this market encompasses several areas, such as responsible sourcing of raw materials, eco-friendly production processes, reducing carbon footprints and offering products that align with consumer demand for clean-label, natural ingredients.

Cargill has been working to end deforestation related to soy production for more than 20 years. They promote sustainable practices to meet the world's growing demand for soy in food, animal feed and biofuels driven by increasing nutritional needs, changing dietary habits and desire for fossil-fuel alternatives. Cargill's role in the soy supply chain comes with significant responsibility and they are keenly aware of the need to deliver customer solutions in a safe, responsible and sustainable way.

By Source

  • Plant Based
    • Soy
    • Sunflower
    • Rapeseed (Canola)
  • Animal Based
    • Guinea Pig
    • Bovine

By Type

  • Hydrolyzed Lysolecithin
    • Fluid Hydrolyzed
    • De-oiled Hydrolyzed
  • Chemically Modified Lysolecithin
  • Others

By Form

  • Powder
  • Liquid
  • Granules

By Application

  • Confectionery
  • Bakery
  • Food Supplements
  • Animal Feed
  • Dairy Products
  • Personal Care and Cosmetics
  • Plant Based Alternatives
  • Others

By End-User

  • Food and Beverage
  • Pharmaceuticals
  • Cosmetics
  • Nutraceuticals

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, Cosphatec launched two new products, Cosphaderm E NGM Natural and Cosphaderm PA-12, that adhere to the COSMOS and NATRUE certification standards for natural and organic cosmetic ingredients. This launch underscores Cosphatec's dedication to providing sustainable and eco-friendly raw materials for the cosmetics industry. Cosphaderm E NGM Natural is a liquid lysolecithin derived from soybeans.
  • In 2023, Prathista Industries introduced a non-hormonal and naturally occurring feed supplement known as Pro-Lyso (Lysolecithin), developed in collaboration with the Indian Institute of Chemical Technology (IICT) in Hyderabad. This innovative product utilizes established biotechnology processes to enhance animal nutrition, specifically targeting poultry and shrimp.
  • In July 2022, Amitex India introduced the AmiLife Enzymatically Hydrolyzed Soya Lecithin (E322). It is derived from non-GMO soy lecithin. Through enzymatic hydrolysis, this lecithin undergoes modification to optimize its functional properties, making it suitable for diverse applications in the food industry and animal nutrition sectors.

Why Purchase the Report?

  • To visualize the global lysolecithin market segmentation based on source, type, form, application, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the global lysolecithin market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global Lysolecithin market report would provide approximately 78 tables, 77 figures and 215 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Type
  • 3.3. Snippet by Form
  • 3.4. Snippet by Application
  • 3.5. Snippet by End-User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Consumer Awareness of Health Benefits
      • 4.1.1.2. Increasing Number of Drug Formulations
    • 4.1.2. Restraints
      • 4.1.2.1. Availability of Cheaper Synthetic Emulsifiers
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. SWOT Analysis
  • 5.6. Supply Chain Analysis
  • 5.7. Value Chain Analysis
  • 5.8. Import and Export Analysis
  • 5.9. Clinical Trial Analysis
  • 5.10. Consumer Analysis
  • 5.11. Sustainability Analysis
  • 5.12. Heat Maps
  • 5.13. B2B Analysis

6. By Source

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 6.1.2. Market Attractiveness Index, By Source
  • 6.2. Plant Based*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Soy
    • 6.2.4. Sunflower
    • 6.2.5. Rapeseed (Canola)
  • 6.3. Animal Based
    • 6.3.1. Guinea Pig
    • 6.3.2. Bovine

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Hydrolyzed Lysolecithin*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Fluid Hydrolyzed
    • 7.2.4. De-oiled Hydrolyzed
  • 7.3. Chemically Modified Lysolecithin
  • 7.4. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Powder*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Liquid
  • 8.4. Granules

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Confectionery*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Bakery
  • 9.4. Food Supplements
  • 9.5. Animal Feed
  • 9.6. Dairy Products
  • 9.7. Personal Care and Cosmetics
  • 9.8. Plant Based Alternatives
  • 9.9. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Food and Beverage*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Pharmaceuticals
  • 10.4. Cosmetics
  • 10.5. Nutraceuticals

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. US
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. UK
      • 11.3.8.3. France
      • 11.3.8.4. Italy
      • 11.3.8.5. Spain
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. Australia
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Kemin Industries, Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Cargill, Inc.
  • 13.3. Lipoid GmbH
  • 13.4. Sternchemie GmbH & Co. KG
  • 13.5. Alexmo Cosmetics
  • 13.6. Cayman Chemical
  • 13.7. Creative Biolabs
  • 13.8. GlpBio Technology
  • 13.9. Larodan AB
  • 13.10. Biosynth Ltd

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us